| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.04 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.094 | 0.04 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |